Logo image of MORT

VANECK MORTGAGE REIT INCOME (MORT) Stock Price, Quote, News and Overview

NYSEARCA:MORT - NYSE Arca - US92189F4524 - ETF - Currency: USD

11.51  -0.11 (-0.95%)

After market: 11.55 +0.04 (+0.35%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MORT. MORT was compared to 83 industry peers in the Automobile Components industry. While MORT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MORT has a bad growth rate and is valued cheaply. Finally MORT also has an excellent dividend rating. These ratings would make MORT suitable for value and dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MORT had positive earnings in the past year.
MORT had a positive operating cash flow in the past year.
In the past 5 years MORT has always been profitable.
MORT had a positive operating cash flow in each of the past 5 years.
MORT Yearly Net Income VS EBIT VS OCF VS FCFMORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

1.2 Ratios

The Return On Assets of MORT (5.28%) is better than 89.16% of its industry peers.
The Return On Equity of MORT (10.77%) is better than 87.95% of its industry peers.
MORT's Return On Invested Capital of 9.29% is amongst the best of the industry. MORT outperforms 87.95% of its industry peers.
MORT had an Average Return On Invested Capital over the past 3 years of 9.16%. This is in line with the industry average of 9.58%.
The 3 year average ROIC (9.16%) for MORT is below the current ROIC(9.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROIC 9.29%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
MORT Yearly ROA, ROE, ROICMORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

MORT has a better Profit Margin (6.93%) than 92.77% of its industry peers.
MORT's Profit Margin has declined in the last couple of years.
MORT has a better Operating Margin (12.44%) than 95.18% of its industry peers.
In the last couple of years the Operating Margin of MORT has remained more or less at the same level.
MORT has a Gross Margin of 29.25%. This is amongst the best in the industry. MORT outperforms 86.75% of its industry peers.
In the last couple of years the Gross Margin of MORT has remained more or less at the same level.
Industry RankSector Rank
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
MORT Yearly Profit, Operating, Gross MarginsMORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MORT is creating some value.
Compared to 1 year ago, MORT has about the same amount of shares outstanding.
The number of shares outstanding for MORT has been reduced compared to 5 years ago.
The debt/assets ratio for MORT has been reduced compared to a year ago.
MORT Yearly Shares OutstandingMORT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
MORT Yearly Total Debt VS Total AssetsMORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.16 indicates that MORT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MORT (2.16) is worse than 67.47% of its industry peers.
MORT has a debt to FCF ratio of 2.88. This is a good value and a sign of high solvency as MORT would need 2.88 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.88, MORT belongs to the top of the industry, outperforming 92.77% of the companies in the same industry.
MORT has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
MORT's Debt to Equity ratio of 0.40 is fine compared to the rest of the industry. MORT outperforms 79.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Altman-Z 2.16
ROIC/WACC1.54
WACC6.02%
MORT Yearly LT Debt VS Equity VS FCFMORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.82 indicates that MORT should not have too much problems paying its short term obligations.
MORT's Current ratio of 1.82 is fine compared to the rest of the industry. MORT outperforms 71.08% of its industry peers.
A Quick Ratio of 1.11 indicates that MORT should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.11, MORT is doing good in the industry, outperforming 69.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.11
MORT Yearly Current Assets VS Current LiabilitesMORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

3

3. Growth

3.1 Past

The earnings per share for MORT have decreased strongly by -19.52% in the last year.
MORT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.63% yearly.
The Revenue has decreased by -5.57% in the past year.
MORT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.17% yearly.
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%

3.2 Future

MORT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.57% yearly.
MORT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.41% yearly.
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MORT Yearly Revenue VS EstimatesMORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
MORT Yearly EPS VS EstimatesMORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.11, the valuation of MORT can be described as very cheap.
100.00% of the companies in the same industry are more expensive than MORT, based on the Price/Earnings ratio.
MORT is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 3.11, which indicates a rather cheap valuation of MORT.
Based on the Price/Forward Earnings ratio, MORT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
MORT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 4.11
Fwd PE 3.11
MORT Price Earnings VS Forward Price EarningsMORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

97.59% of the companies in the same industry are more expensive than MORT, based on the Enterprise Value to EBITDA ratio.
100.00% of the companies in the same industry are more expensive than MORT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.66
EV/EBITDA 2.13
MORT Per share dataMORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

MORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of MORT may justify a higher PE ratio.
A more expensive valuation may be justified as MORT's earnings are expected to grow with 12.80% in the coming years.
PEG (NY)0.23
PEG (5Y)1.13
EPS Next 2Y13.1%
EPS Next 3Y12.8%

7

5. Dividend

5.1 Amount

MORT has a Yearly Dividend Yield of 4.02%, which is a nice return.
Compared to an average industry Dividend Yield of 4.03, MORT has a dividend in line with its industry peers.
MORT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

On average, the dividend of MORT grows each year by 7.12%, which is quite nice.
MORT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.12%
Div Incr Years0
Div Non Decr Years0
MORT Yearly Dividends per shareMORT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

MORT pays out 50.00% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of MORT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
MORT Yearly Income VS Free CF VS DividendMORT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B
MORT Dividend Payout.MORT Dividend Payout, showing the Payout Ratio.MORT Dividend Payout.PayoutRetained Earnings

VANECK MORTGAGE REIT INCOME

NYSEARCA:MORT (2/21/2025, 8:04:00 PM)

After market: 11.55 +0.04 (+0.35%)

11.51

-0.11 (-0.95%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-24 2025-04-24
Inst Owners40.02%
Inst Owner Change4.28%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap8.12B
Analysts75.71
Price Target12.32 (7.04%)
Short Float %0.08%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend1.25
Dividend Growth(5Y)7.12%
DP50%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.93%
PT rev (3m)-7.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.68%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 4.11
Fwd PE 3.11
P/S 0.28
P/FCF 2.66
P/OCF 1.5
P/B 0.44
P/tB 0.6
EV/EBITDA 2.13
EPS(TTM)2.8
EY24.33%
EPS(NY)3.7
Fwd EY32.15%
FCF(TTM)4.32
FCFY37.56%
OCF(TTM)7.68
OCFY66.73%
SpS41.05
BVpS26.41
TBVpS19.32
PEG (NY)0.23
PEG (5Y)1.13
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROCE 12.25%
ROIC 9.29%
ROICexc 10.6%
ROICexgc 13.08%
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
FCFM 10.53%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
ROICexc(3y)10.41%
ROICexc(5y)9.64%
ROICexgc(3y)12.74%
ROICexgc(5y)11.9%
ROCE(3y)12.06%
ROCE(5y)11.19%
ROICexcg growth 3Y13.26%
ROICexcg growth 5Y0.75%
ROICexc growth 3Y14.02%
ROICexc growth 5Y1.17%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Debt/EBITDA 1.31
Cap/Depr 116.24%
Cap/Sales 8.18%
Interest Coverage 10.15
Cash Conversion 96.06%
Profit Quality 152.03%
Current Ratio 1.82
Quick Ratio 1.11
Altman-Z 2.16
F-Score6
WACC6.02%
ROIC/WACC1.54
Cap/Depr(3y)109.9%
Cap/Depr(5y)100.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%
EBIT growth 1Y2.68%
EBIT growth 3Y23.2%
EBIT growth 5Y4.75%
EBIT Next Year61.62%
EBIT Next 3Y21.75%
EBIT Next 5Y16.53%
FCF growth 1Y7589.47%
FCF growth 3Y12.46%
FCF growth 5Y21.28%
OCF growth 1Y171.92%
OCF growth 3Y16.24%
OCF growth 5Y13.31%